SCHEMBL6140971

SCHEMBL6140971

Cc1cc(N)ccc1N1C(=O)CCCC1=O

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 2/20 0.59
HPGD P15428 2/20 0.59
KMT2A Q03164 8/20 0.53
MAPT P10636 4/20 0.53
ALDH1A1 P00352 4/20 0.53
GAA P10253 3/20 0.53
MEN1 O00255 3/20 0.53
THRB P10828 2/20 0.53
NR4A1 P22736 1/20 0.53
PTK2B Q14289 1/20 0.53
LMNA P02545 2/20 0.49
ALOX15 P16050 2/20 0.49
KDM4E B2RXH2 1/20 0.49
POLB P06746 1/20 0.48
APEX1 P27695 1/20 0.48
CASP6 P55212 1/20 0.48
CTDSP1 Q9GZU7 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
MAPK1 P28482 1/20 0.47
ATAD2 Q6PL18 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6140550 0.93 TP53 (0.68) TP53HPGDKMT2AMAPTALDH1A1
SCHEMBL718092 0.82 HPGD (0.62) TP53HPGDKMT2AMAPTALDH1A1
SCHEMBL30168124 0.81 HSD17B10 (0.59) TP53HPGDKMT2AMAPTALDH1A1
SCHEMBL3866085 0.81 HSD17B10 (0.59) TP53HPGDKMT2AMAPTALDH1A1
SCHEMBL76351 0.80 KMT2A (0.58) TP53HPGDKMT2AMAPTALDH1A1
SCHEMBL6141020 0.79 NR4A1 (0.51) TP53HPGDKMT2AMAPTALDH1A1
SCHEMBL5425961 0.79 KMT2A (0.57) TP53HPGDKMT2AMAPTALDH1A1
SCHEMBL6140202 0.76 GAA (0.44) TP53HPGDKMT2AMAPTALDH1A1
SCHEMBL22273614 0.76 KDM4E (0.51) TP53HPGDKMT2AMAPTALDH1A1
SCHEMBL719077 0.74 SMN1; SMN2 (0.62) TP53HPGDKMT2AMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050182260-A1 Process for the preparation of cyclic imides in the presence of polyphosphoric acid MERCK PATENT GMBH (DE) 2005-08-18 US disclosed
EP-1506173-A1 METHOD FOR PRODUCING CYCLIC IMIDES IN THE PRESENCE OF POLYPHOSPHORIC ACID MERCK PATENT GmbH (DE) 2005-02-16 EP disclosed
WO-2003097600-A1 METHOD FOR PRODUCING CYCLIC IMIDES IN THE PRESENCE OF POLYPHOSPHORIC ACID MERCK PATENT GMBH (DE) 2003-11-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050182260-A1 Process for the preparation of cyclic imides in the presence of polyphosphoric acid PPIP5K2, ITPA, IPMK TP53 4419/4885HPGD 700/4885KMT2A 4192/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.